Integrins and p53 pathways in glioblastoma resistance to temozolomide.

Integrins and p53 pathways in glioblastoma resistance to temozolomide.

Item
http://www.wikidata.org/entity/Q41630032
β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of CancerA nanoparticle carrying the p53 gene targets tumors including cancer stem cells, sensitizes glioblastoma to chemotherapy and improves survival.Reduction in gap junction intercellular communication promotes glioma migration.Integrin β1-mediated acquired gefitinib resistance in non-small cell lung cancer cells occurs via the phosphoinositide 3-kinase-dependent pathway.CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion.Migration pattern, actin cytoskeleton organization and response to PI3K-, mTOR-, and Hsp90-inhibition of glioblastoma cells with different invasive capacities.A stapled peptide antagonist of MDM2 carried by polymeric micelles sensitizes glioblastoma to temozolomide treatment through p53 activation.Effect of p53 activity on the sensitivity of human glioblastoma cells to PARP-1 inhibitor in combination with topoisomerase I inhibitor or radiation.The p53 Pathway in Glioblastoma
P2860

Integrins and p53 pathways in glioblastoma resistance to temozolomide.

Item
http://www.wikidata.org/entity/Q41630032
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Integrins and p53 pathways in glioblastoma resistance to temozolomide.
@en
type
label
Integrins and p53 pathways in glioblastoma resistance to temozolomide.
@en
prefLabel
Integrins and p53 pathways in glioblastoma resistance to temozolomide.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P932
P356
P1433
P1476
Integrins and p53 pathways in glioblastoma resistance to temozolomide.
@en
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P932